{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T03:57:18Z","timestamp":1772251038479,"version":"3.50.1"},"reference-count":31,"publisher":"BMJ","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["British Journal of Ophthalmology"],"published-print":{"date-parts":[[1996,2,1]]},"DOI":"10.1136\/bjo.80.2.182","type":"journal-article","created":{"date-parts":[[2007,9,18]],"date-time":"2007-09-18T21:53:19Z","timestamp":1190152399000},"page":"182-184","source":"Crossref","is-referenced-by-count":29,"title":["Widespread ocular use of topical chloramphenicol: is there justifiable concern regarding idiosyncratic aplastic anaemia?"],"prefix":"10.1136","volume":"80","author":[{"given":"C N","family":"McGhee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C N","family":"Anastas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1136\/bmj.310.6989.1217","article-title":"Use of chloramphenicol as topical eye medication: time to cry halt?","volume":"310","author":"Doona, M.; Walsh, J.B.","year":"1995","unstructured":"Doona M, Walsh JB. Use of chloramphenicol as topical eye medication: time to cry halt? [Editorial]. BMJ 1995; 310: 1217-8.","journal-title":"BMJ"},{"key":"ref_2","first-page":"vii","article-title":"Topical chloramphenicol: use or abuse?","author":"Kirkness, C.M.; Seal, D.V.; Hay, J.","year":"1995","unstructured":"Kirkness CM, Seal DV, Hay J. Topical chloramphenicol: use or abuse? Eye 1995; 9 (4): vii-viii."},{"key":"ref_3","first-page":"450","article-title":"Is it time to stop using chloramphenicol on the eye? Safe in patients with no history of blood dyscrasias","volume":"311","author":"Buckley, R.J.K.; Kirkness, C.M.; Kanski, J.J.; Ridgway, A.E.A.; Tullo, A.B.; Watson, P.G.","year":"1995","unstructured":"Buckley RJK, Kirkness CM, Kanski JJ, Ridgway AEA, Tullo AB, Watson PG. Is it time to stop using chloramphenicol on the eye? Safe in patients with no history of blood dyscrasias [Letter]. BMJ 1995; 311: 450.","journal-title":"BMJ"},{"key":"ref_4","first-page":"450","article-title":"Is it time to stop using chloramphenicol on the eye? Risk is low in short courses","volume":"311","author":"Hall, A.V.; Das, S.S.; Tabaqchali, S.","year":"1995","unstructured":"Hall AV, Das SS, Tabaqchali S. Is it time to stop using chloramphenicol on the eye? Risk is low in short courses [Letter]. BMJ 1995; 311: 450-1.","journal-title":"BMJ"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1136\/bmj.311.7002.451a","article-title":"Is it time to stop using chloramphenicol on the eye? Prospective study of aplastic anaemia should give definitive answer","volume":"311","author":"Gordon-Smith, E.C.; Marsh, J.C.W.; Geary, C.G.","year":"1995","unstructured":"Gordon-Smith EC, Marsh JCW, Geary CG. Is it time to stop using chloramphenicol on the eye? Prospective study of aplastic anaemia should give definitive answer [Letter]. BMJ 1995; 311: 451.","journal-title":"BMJ"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.7326\/0003-4819-33-6-1459","article-title":"A fatal case of aplastic anaemia following chloramphenicol (chloromycetin) therapy","volume":"33","author":"Rich, M.L.; Ritterhoff, R.J.; Hoffman, R.J.","year":"1950","unstructured":"Rich ML, Ritterhoff RJ, Hoffman RJ. A fatal case of aplastic anaemia following chloramphenicol (chloromycetin) therapy. Ann Intern Med 1950; 33: 1459-67.","journal-title":"Ann Intern Med"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"167","DOI":"10.2165\/00002018-199207030-00001","article-title":"Chloramphenicol: are concerns about aplastic anaemia justified?","volume":"7","author":"Flegg, P.; Cheong, I.; Welsby, P.D.","year":"1992","unstructured":"Flegg P, Cheong I, Welsby PD. Chloramphenicol: are concerns about aplastic anaemia justified? Drug Safety 1992; 7:167-9.","journal-title":"Drug Safety"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1001\/jama.1967.03130030051012","article-title":"Chloramphenicol-associated blood dyscrasias","author":"Best, W.R.","year":"1967","unstructured":"Best WR. Chloramphenicol-associated blood dyscrasias.JAMA 1967; 201: 181-8.","journal-title":"JAMA"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1136\/bmj.300.6738.1497","article-title":"Survey of patients taking topical medication at their first presentation to eye casualty","volume":"300","author":"Buckley, S.A.","year":"1990","unstructured":"Buckley SA. Survey of patients taking topical medication at their first presentation to eye casualty. BMJ 1990; 300: 1497-8.","journal-title":"BMJ"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1016\/S0025-6196(12)62479-3","article-title":"Tetracyclines, chloramphenicol, erythromycin, clindamycin and metronidazole","volume":"66","year":"1991","unstructured":"Smilack JD, Wilson WR, Cockerill FR. Tetracyclines, chloramphenicol, erythromycin, clindamycin and metronidazole. Mayo ClinProc 1991; 66: 1270-80.","journal-title":"Mayo ClinProc"},{"key":"ref_11","first-page":"274","article-title":"Antimicrobials","volume-title":"ocular pharmacology","author":"Mauger, T.F.","year":"1994","unstructured":"Mauger TF. Antimicrobials. In: Mauger TF, Craig EL, eds. Havener's ocular pharmacology. 6th ed. St Louis: Mosby, 1994: 274-8.","edition":"6th ed"},{"issue":"66","key":"ref_12","first-page":"104","article-title":"Stable chloramphenicol solution for ocular infections","volume":"1968","author":"Aragones, J.V.; Eriksen, S.P.","unstructured":"Aragones JV, Eriksen SP. Stable chloramphenicol solution for ocular infections. Am I Ophthalmol 1968; 66: 104-6.","journal-title":"Am I Ophthalmol"},{"key":"ref_13","first-page":"468","article-title":"A comparison of fusidic acid viscous eye drops and chloramphenicol eye ointment in acute conjunctivitis","volume":"44","author":"Sinclair, N.M.; Leigh, D.A.","year":"1988","unstructured":"Sinclair NM, Leigh DA. A comparison of fusidic acid viscous eye drops and chloramphenicol eye ointment in acute conjunctivitis. Therapeutic Res 1988; 44: 468-74.","journal-title":"Therapeutic Res"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1001\/archopht.1975.01010020192004","article-title":"Chloramphenicol in aqueous humor after topical application","volume":"93","author":"Beasley, H.; BoltralikJJ, Baldwin; H.A.","year":"1975","unstructured":"Beasley H, BoltralikJJ, Baldwin HA. Chloramphenicol in aqueous humor after topical application. Arch Ophthalmol 1975; 93: 184-5.","journal-title":"Arch Ophthalmol"},{"key":"ref_15","article-title":"Martindale: the extra pharmnacapoeia","author":"Reynolds, J.E.F.","year":"1993","unstructured":"Reynolds JEF, ed. Martindale: the extra pharmnacapoeia. 30th ed. London: The Pharmaceutical Press, 1993.","edition":"30th ed"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1136\/bjo.78.7.546","article-title":"Ocular penetration of topical ciprofloxacin and norfloxacin drops and their effect upon eyelid flora","volume":"78","author":"Leeming, J.P.; Diamond, J.P.; Trigg, R.; White, L.; Hoh, H.D.; Easty, D.","year":"1994","unstructured":"Leeming JP, Diamond JP, Trigg R, White L, Hoh HD, Easty D. Ocular penetration of topical ciprofloxacin and norfloxacin drops and their effect upon eyelid flora. BrJ Ophthalmol 1994; 78: 546-8.","journal-title":"BrJ Ophthalmol"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1177\/112067219300300205","article-title":"Evaluation of efficacy and safety of ciprofloxacin ophthalmic solution versus chloramphenicol","volume":"3","author":"Power, W.J.; Collum, L.M.; Easty, D.L.; Bloom, P.A.; Laidlaw, D.A.; Libert, J.","year":"1993","unstructured":"Power WJ, Collum LM, Easty DL, Bloom PA,Laidlaw DA, Libert J, et al. Evaluation of efficacy and safety of ciprofloxacin ophthalmic solution versus chloramphenicol. EurJ Ophthalmol 1993; 3: 77-82.","journal-title":"EurJ Ophthalmol"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1001\/jama.1964.03060320053013","article-title":"Drug-induced blood dyscrasias: I. Aplastic anaemia","volume":"188","author":"Erslev, A.J.","year":"1964","unstructured":"Erslev AJ. Drug-induced blood dyscrasias: I. Aplastic anaemia.JAMA 1964; 188: 159-60.","journal-title":"JAMA"},{"issue":"208","key":"ref_19","first-page":"2045","article-title":"Statewide study of chloramphenicol therapy and fatal aplastic anaemia","volume":"1969","unstructured":"Wallerstein RO, Condit PK, Kasper CK, BrownJW, Morrison FR. Statewide study of chloramphenicol therapy and fatal aplastic anaemia. JAMA 1969; 208: 2045-50.","journal-title":"JAMA"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1136\/bjo.63.10.690","article-title":"Systemic absorption of topically applied chloramphenicol eyedrops","volume":"63","author":"Trope, G.E.; Lawrence, JR, Hind; VMD, Bunney; J.","year":"1979","unstructured":"Trope GE, Lawrence JR, Hind VMD, Bunney J. Systemic absorption of topically applied chloramphenicol eyedrops. Br J Ophthalmol 1979; 63: 690-1.","journal-title":"Br J Ophthalmol"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/0002-9394(82)90540-2","article-title":"Fatal aplastic anaemia following topical administration of ophthalmic chloramphenicol","volume":"93","author":"Fraunfelder, F.T.; Bagby, G.C.; Kelly, D.J.","year":"1982","unstructured":"Fraunfelder FT, Bagby GC, Kelly DJ. Fatal aplastic anaemia following topical administration of ophthalmic chloramphenicol. Am J Ophthalmol 1982; 93: 356-60.","journal-title":"Am J Ophthalmol"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1001\/archinte.1980.00330160136049","article-title":"Marrow aplasia following topical application of chloramphenicol eye ointment","volume":"140","author":"Abrams, S.M.; DegnanTJ, Vinciguerra; V.","year":"1980","unstructured":"Abrams SM, DegnanTJ, Vinciguerra V. Marrow aplasia following topical application of chloramphenicol eye ointment. Arch Intern Med 1980; 140: 576-7.","journal-title":"Arch Intern Med"},{"key":"ref_23","first-page":"7","article-title":"Concordance for drug-induced aplastic anaemia in identical twins","volume":"281","author":"Nagao, T.; Mauer, A.M.","year":"1969","unstructured":"Nagao T, Mauer AM. Concordance for drug-induced aplastic anaemia in identical twins. NEngl1MJed 1969; 281: 7-11."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/S0002-9394(14)73653-0","article-title":"Blood dyscrasias and topical ophthalmic chloramphenicol","volume":"115","author":"FaunfelderFT, MorganRL; AA, Yunis","year":"1993","unstructured":"FaunfelderFT, MorganRL, Yunis AA. Blood dyscrasias and topical ophthalmic chloramphenicol. AmJI Ophthalmol 1993; 115: 812-3.","journal-title":"AmJI Ophthalmol"},{"key":"ref_25","first-page":"148","article-title":"Bone-marrow hypoplasia following use of chloramphenicol eye drops","volume":"191","author":"Rosenthal, R.L.; Blackman, A.","year":"1965","unstructured":"Rosenthal RL, Blackman A. Bone-marrow hypoplasia following use of chloramphenicol eye drops. JAM A 1965; 191: 148-9.","journal-title":"JAM A"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/S0140-6736(75)92766-X","article-title":"Chloramphenicol eye-drops and marrow aplasia","volume":"ii:","author":"Carpenter, G.","year":"1975","unstructured":"Carpenter G. Chloramphenicol eye-drops and marrow aplasia. Lancet 1975; ii: 326-7.","journal-title":"Lancet"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/S0002-9394(14)75650-8","article-title":"Chloramphenicol and aplastic anaemia","volume":"92","author":"Dutro, M.P.","year":"1981","unstructured":"Dutro MP. Chloramphenicol and aplastic anaemia. Am J Ophthalmol 1981; 92: 870-1.","journal-title":"Am J Ophthalmol"},{"key":"ref_28","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(87)91148-2","article-title":"Ophthalmic use of chloramphenicol","author":"Stevens, J.D.; Mission, G.P.","year":"1987","unstructured":"Stevens JD, Mission GP. Ophthalmic use of chloramphenicol [Letter]. Lancet 1987; ii: 1456.","journal-title":"Lancet"},{"key":"ref_29","first-page":"1081","article-title":"Penicillins, cephalosporins, and other beta-lactam antibiotics","volume-title":"The pharmacological basis of therapeutics. Vol II","author":"Mandell, G.L.; SandMe, A.","year":"1992","unstructured":"Mandell GL, SandMe A. Penicillins, cephalosporins, and other beta-lactam antibiotics. IGn:oodman Gilman A, Rall TW, Nies AS, Taylor P, ed. The pharmacological basis of therapeutics. Vol II. 8th ed. Singapore: McGrawHill Book Co, 1992: 1081-5.","edition":"8th ed"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1111\/j.1365-2885.1994.tb00246.x","article-title":"Pharmacokinetic and toxocological aspects of the medication of beef-type calves with an oral formulation of chloramphenicol palmitJatef","volume":"17","author":"Gassner, B.; Wuethrich, A.","year":"1994","unstructured":"Gassner B, Wuethrich A. Pharmacokinetic and toxocological aspects of the medication of beef-type calves with an oral formulation of chloramphenicol palmitJatef. Vet Pharmacol Ther 1994; 17: 279-83.","journal-title":"Vet Pharmacol Ther"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1751-0813.1991.tb09826.x","article-title":"I: Hazards of use and current regulatory environment","volume":"68","author":"Chloramphenicol, Page S.W.","year":"1991","unstructured":"Page SW. Chloramphenicol. I: Hazards of use and current regulatory environment. Aust Vet J 1991; 68: 1-2.","journal-title":"Aust Vet J"}],"container-title":["British Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bjo.80.2.182","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,26]],"date-time":"2020-09-26T10:28:54Z","timestamp":1601116134000},"score":1,"resource":{"primary":{"URL":"https:\/\/bjo.bmj.com\/lookup\/doi\/10.1136\/bjo.80.2.182"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1996,2,1]]},"references-count":31,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1996,2,1]]}},"URL":"https:\/\/doi.org\/10.1136\/bjo.80.2.182","relation":{},"ISSN":["0007-1161"],"issn-type":[{"value":"0007-1161","type":"print"}],"subject":[],"published":{"date-parts":[[1996,2,1]]}}}